Sign up to our newsletter Subscribe
The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK

Comment, press releases and other news from OHE.
Our monthly Bulletin highlights our work alongside the latest from across health economics and health care.